These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 2737234)

  • 1. Influence of a very low calorie diet on the clearance of oxazepam and antipyrine in man.
    Sonne J; Dragsted J; Loft S; Døssing M; Andreasen F
    Eur J Clin Pharmacol; 1989; 36(4):407-9. PubMed ID: 2737234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antipyrine, oxazepam, and indocyanine green clearance in patients with chronic pancreatitis and healthy subjects.
    Andersen V; Sonne J; Larsen S
    Scand J Gastroenterol; 1999 Aug; 34(8):813-7. PubMed ID: 10499483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of dietary energy and protein deficiency on drug metabolism.
    Hamberg O; Ovesen L; Dorfeldt A; Loft S; Sonne J
    Eur J Clin Pharmacol; 1990; 38(6):567-70. PubMed ID: 2373130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of the effects of a macrobiotic diet and a Western diet on drug metabolism and plasma lipids in man.
    Wissel PS; Denke M; Inturrisi CE
    Eur J Clin Pharmacol; 1987; 33(4):403-7. PubMed ID: 3443147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucuronidation of oxazepam is not spared in patients with hepatic encephalopathy.
    Sonne J; Andreasen PB; Loft S; Døssing M; Andreasen F
    Hepatology; 1990 Jun; 11(6):951-6. PubMed ID: 2365292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dietary influences on the kinetics of antipyrine and aminopyrine in human subjects.
    Krishnaswamy K; Kalamegham R; Naidu NA
    Br J Clin Pharmacol; 1984 Feb; 17(2):139-46. PubMed ID: 6704283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antipyrine disposition in obesity: evidence for negligible effect of obesity on hepatic oxidative metabolism.
    Caraco Y; Zylber-Katz E; Berry EM; Levy M
    Eur J Clin Pharmacol; 1995; 47(6):525-30. PubMed ID: 7768256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of protein and carbohydrate content of diet on drug conjugation.
    Pantuck EJ; Pantuck CB; Kappas A; Conney AH; Anderson KE
    Clin Pharmacol Ther; 1991 Sep; 50(3):254-8. PubMed ID: 1914359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors and conditions affecting the glucuronidation of oxazepam.
    Sonne J
    Pharmacol Toxicol; 1993; 73 Suppl 1():1-23. PubMed ID: 8415417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On the regulation of antipyrine and oxazepam metabolism in man.
    Kellermann GH; Luyten-Kellermann M
    Res Commun Chem Pathol Pharmacol; 1979 Feb; 23(2):287-96. PubMed ID: 461954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced glucuronide conjugation of drugs in obesity: studies of lorazepam, oxazepam, and acetaminophen.
    Abernethy DR; Greenblatt DJ; Divoll M; Shader RI
    J Lab Clin Med; 1983 Jun; 101(6):873-80. PubMed ID: 6133901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics and pharmacodynamics of oxazepam and metabolism of paracetamol in severe hypothyroidism.
    Sonne J; Boesgaard S; Poulsen HE; Loft S; Hansen JM; Døssing M; Andreasen F
    Br J Clin Pharmacol; 1990 Nov; 30(5):737-42. PubMed ID: 2271373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single dose pharmacokinetics and pharmacodynamics of oral oxazepam in very elderly institutionalised subjects.
    Sonne J; Loft S; Døssing M; Boesgaard S; Andreasen F
    Br J Clin Pharmacol; 1991 Jun; 31(6):719-22. PubMed ID: 1867967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioavailability and pharmacokinetics of oxazepam.
    Sonne J; Loft S; Døssing M; Vollmer-Larsen A; Olesen KL; Victor M; Andreasen F; Andreasen PB
    Eur J Clin Pharmacol; 1988; 35(4):385-9. PubMed ID: 3197746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of a low-calorie diet on serum lipid levels and metabolic function of the liver in obese women during the climacteric period].
    Chojnowska-Jezierska J; Kowalczyk-Gawrysiak L; Tkaczewski W
    Wiad Lek; 1989 Dec; 41(23):1566-70. PubMed ID: 2763556
    [No Abstract]   [Full Text] [Related]  

  • 16. Antipyrine pharmacokinetics in women receiving conjugated estrogens.
    Scavone JM; Greenblatt DJ; Blyden GT
    J Clin Pharmacol; 1988 May; 28(5):463-6. PubMed ID: 3392245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accuracy of the one-sample method for determination of antipyrine clearance in elderly subjects.
    Jorquera F; Almar MM; González-Sastre M; Suarez I; González-Gallego J
    J Pharm Biomed Anal; 1996 Oct; 15(1):7-11. PubMed ID: 8895071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antipyrine clearance in surgical patients maintained on hypocaloric peripheral parenteral nutrition.
    Jorquera F; Almar M; Martinez C; Gonzalez-Sastre M; Culebras JM; Gonzalez-Gallego J
    JPEN J Parenter Enteral Nutr; 1994; 18(6):544-8. PubMed ID: 7602731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of physical exercise on one-sample antipyrine clearance.
    Fabbri A; Bianchi G; Zoli M; Marchi E; Marchesini G
    Ital J Gastroenterol; 1991 Feb; 23(2):74-6. PubMed ID: 1747507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of dietary protein and carbohydrate on antipyrine and theophylline metabolism in man.
    Kappas A; Anderson KE; Conney AH; Alvares AP
    Clin Pharmacol Ther; 1976 Dec; 20(6):643-53. PubMed ID: 991535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.